Piretanide

吡咯他尼

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NamePiretanide

Drug Alias Name苯氧吡酸PiretanidaPiretanidum苯吡磺苯酸Eurelix +[9]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitors

TargetsSodium-(potassium)-chloride cotransporter 2

Therapy Area/IndicationsEdemaHypertensionHeart Failure

Global Approved IndicationsEdemaHypertensionHeart Failure

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved Date1981/01/01

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsEdemaHypertensionHeart Failure

Inactive IndicationsN/A

ATC CodeC03CA03